These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 10548454)

  • 1. Human moricizine metabolism. II. Quantification and pharmacokinetics of plasma and urinary metabolites.
    Pieniaszek HJ; Davidson AF; Chaney JE; Shum L; Robinson CA; Mayersohn M
    Xenobiotica; 1999 Sep; 29(9):945-55. PubMed ID: 10548454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human moricizine metabolism. I. Isolation and identification of metabolites in human urine.
    Richards LE; Pieniaszek HJ; Shatzmiller S; Page GO; Blom KF; Read JM; Davidson AF; Confalone PN
    Xenobiotica; 1997 Feb; 27(2):217-29. PubMed ID: 9058534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disposition of moracizine (ethmozine) in healthy subjects after oral administration of radiolabelled drug.
    Howrie DL; Pieniaszek HJ; Fogoros RN; Juhl RP; Schary WL; Whitney CC; Dittert LW
    Eur J Clin Pharmacol; 1987; 32(6):607-10. PubMed ID: 3308487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of moricizine HCl.
    Woosley RL; Morganroth J; Fogoros RN; McMahon FG; Humphries JO; Mason DT; Williams RL
    Am J Cardiol; 1987 Oct; 60(11):35F-39F. PubMed ID: 3310583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetic interactions of moricizine and diltiazem in healthy volunteers.
    Shum L; Pieniaszek HJ; Robinson CA; Davidson AF; Widner PJ; Benedek IH; Flamenbaum W
    J Clin Pharmacol; 1996 Dec; 36(12):1161-8. PubMed ID: 9013374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Moricizine bioavailability via simultaneous, dual, stable isotope administration: bioequivalence implications.
    Pieniaszek HJ; Mayersohn M; Adams MP; Reinhart RJ; Barrett JS
    J Clin Pharmacol; 1999 Aug; 39(8):817-25. PubMed ID: 10434234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of hepatic disease on the disposition of moricizine in humans.
    Pieniaszek HJ; Davidson AF; McEntegart CM; Quon CY; Sampliner RE; Mayersohn M
    Biopharm Drug Dispos; 1994 Apr; 15(3):243-52. PubMed ID: 7880984
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isolation and characterization of sulphoxidation metabolites of moricizine in rat and human biological fluids.
    Yang JM; Chan K
    Methods Find Exp Clin Pharmacol; 1995; 17(6):415-21. PubMed ID: 8642903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dose proportionality of moricizine after escalating multiple doses in healthy volunteers.
    Benedek IH; Garner DM; Pieniaszek HJ
    J Clin Pharmacol; 1991 Mar; 31(3):229-32. PubMed ID: 2019664
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Moricizine concentration to guide arrhythmia treatment: with attention to elderly patients.
    Giardina EG; Wechsler ME; Dolgopiatova M; Sciacca R
    J Clin Pharmacol; 1994 Jul; 34(7):725-33. PubMed ID: 7523457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolism and elimination of 14C-donepezil in healthy volunteers: a single-dose study.
    Tiseo PJ; Perdomo CA; Friedhoff LT
    Br J Clin Pharmacol; 1998 Nov; 46 Suppl 1(Suppl 1):19-24. PubMed ID: 9839761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical pharmacokinetics of moricizine.
    Siddoway LA; Schwartz SL; Barbey JT; Woosley RL
    Am J Cardiol; 1990 Feb; 65(8):21D-25D; discussion 68D-71D. PubMed ID: 2407090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enzyme induction by moricizine: time course and extent in healthy subjects.
    Benedek IH; Davidson AF; Pieniaszek HJ
    J Clin Pharmacol; 1994 Feb; 34(2):167-75. PubMed ID: 8163717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of food on the oral absorption and bioavailability of moricizine.
    Pieniaszek HJ; Rakestraw DC; Schary WL; Williams RL
    J Clin Pharmacol; 1991 Sep; 31(9):792-5. PubMed ID: 1804860
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The disposition and metabolic fate of 14C-meropenem in man.
    Harrison MP; Haworth SJ; Moss SR; Wilkinson DM; Featherstone A
    Xenobiotica; 1993 Nov; 23(11):1311-23. PubMed ID: 8310714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sucralose metabolism and pharmacokinetics in man.
    Roberts A; Renwick AG; Sims J; Snodin DJ
    Food Chem Toxicol; 2000; 38 Suppl 2():S31-41. PubMed ID: 10882816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The metabolic profile of azimilide in man: in vivo and in vitro evaluations.
    Riley P; Figary PC; Entwisle JR; Roe AL; Thompson GA; Ohashi R; Ohashi N; Moorehead TJ
    J Pharm Sci; 2005 Sep; 94(9):2084-95. PubMed ID: 16052551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The disposition of [14C]-labelled benazepril HCl in normal adult volunteers after single and repeated oral dose.
    Waldmeier F; Kaiser G; Ackermann R; Faigle JW; Wagner J; Barner A; Lasseter KC
    Xenobiotica; 1991 Feb; 21(2):251-61. PubMed ID: 2058180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simultaneous determination of moricizine and its sulphoxidation metabolites in biological fluids by high-performance liquid chromatography.
    Yang JM; Chan K
    J Chromatogr B Biomed Appl; 1995 Jan; 663(1):172-6. PubMed ID: 7704207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The disposition and metabolic fate of 14C-cibenzoline in man.
    Massarella JW; Loh AC; Williams TH; Szuna AJ; Sandor D; Bressler R; Leinweber FJ
    Drug Metab Dispos; 1986; 14(1):59-64. PubMed ID: 2868867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.